This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pfizer Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher Lee McClendon: Innovator in AMPK Activation Compounds
Introduction
Christopher Lee McClendon is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that activate AMP-activated protein kinase (AMPK). His work is crucial for advancing therapeutic strategies in various metabolic disorders.
Latest Patents
Christopher Lee McClendon holds 1 patent for his innovative work on "Compounds for the activation of AMPK." This patent describes compounds of Formula I, which have potential applications in enhancing metabolic health and treating related diseases.
Career Highlights
McClendon is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Throughout his career, McClendon has worked alongside talented colleagues, including Gary Erik Aspnes and Christopher Ryan Butler. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Christopher Lee McClendon is a distinguished inventor whose work on AMPK activation compounds holds promise for future medical advancements. His contributions to Pfizer Corporation and collaborations with esteemed colleagues underscore his impact on the field of biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile